| Patient | Martha Canary |
|---|---|
| Date of birth | 1981-05-01 |
| Identifiers | MRN HR-NI008-SYN; SSN (made up) 000-08-9532 |
| Document date | 2026-04-27 |
| Author | Ruth Ann Kessler, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Periodic adult preventive visit. [S]
Ms. Canary is a 44-year-old woman with severe alcohol use disorder in early remission on monthly extended-release naltrexone, and alcohol-associated steatotic liver disease, who comes for her yearly preventive visit four weeks after her four-week review; her second naltrexone injection is due today. She has had no alcohol since intake, eight weeks ago. She has had the urge to drink on a few evenings and called the peer recovery specialist twice. Her tooth socket has healed. She is eating two meals a day with SNAP benefits and has gained weight. She is still staying at her friend's house and is on the waiting list for a room through the housing program. She cannot remember a Pap test or a mammogram, or any vaccines as an adult. [S]
| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 44 |
| Alcohol | None for eight weeks; cravings on a few evenings |
| Naltrexone | Second monthly injection due today |
| Mood | PHQ-9 7; item 9 scored 0 |
| Medicines | Extended-release naltrexone 380 mg every four weeks; thiamine 100 mg and folic acid 1 mg daily |
Health risk assessment. Read aloud and completed with the patient by the clinic's community health worker, at her request, and reviewed with her by Dr. Kessler. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Fair, and better than two months ago |
| Psychosocial | Friends in town; weekly contact with the peer recovery specialist; a women's mutual-help meeting on Thursdays |
| Alcohol | None for eight weeks; AUDIT 31 at intake |
| Tobacco | Chews tobacco daily; does not smoke |
| Physical activity | Physical work most days and walking everywhere |
| Nutrition | Two meals a day on most days with SNAP benefits and the food bank |
| Sleep | Six hours, better than in the first weeks |
| Safety at home | Feels safe where she is staying; no one hurts or threatens her; her rifle is locked at her friend's house |
| Road safety | Does not drive; gets rides or walks |
| Activities of daily living | Independent |
| Hearing and vision | No difficulty |
| Oral health | One molar removed last month; a dental cleaning booked at the community health center |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever, night sweats or weight loss; weight rising |
| Eyes | Negative | No vision change |
| Ears, nose, mouth, and throat | Negative | Extraction site healed |
| Cardiovascular | Negative | No chest pain or palpitations |
| Respiratory | Negative | No cough lasting more than two weeks, no blood in sputum |
| Gastrointestinal | Negative | No abdominal pain, vomiting, black stools or yellowing of the eyes |
| Genitourinary | Negative | Periods irregular; no abnormal bleeding or discharge |
| Musculoskeletal | Negative | Aches after heavy work only |
| Integumentary | Negative | No rash; injection site from the last dose healed |
| Neurological | Negative | No tremor, numbness or unsteadiness |
| Psychiatric | Positive | Some low days and evening cravings; PHQ-9 7; no thoughts of suicide or self-harm |
11 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Gabapentin 300 mg oral capsule on a written five-day schedule for alcohol withdrawal: 300 mg in the morning, 300 mg in the afternoon and 600 mg at bedtime for three days, then 300 mg twice daily on day four, 300 mg at bedtime on day five, then stop; dispensed for the five days only | Per the written five-day schedule | Oral route | 2026-03-02 to 2026-03-06 | completed | S |
| Thiamine 100 mg by intramuscular injection once daily for three days, given in the clinic | 100 mg intramuscularly once daily for three days | Intramuscular route | 2026-03-02 to 2026-03-04 | completed | S |
| Thiamine 100 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-05 | active | S |
| Folic acid 1 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-02 | active | S |
| Potassium chloride extended-release 20 mEq oral tablet, one tablet daily with food for five days | One tablet daily with food for five days | Oral route | 2026-03-02 to 2026-03-06 | completed | S |
| Magnesium oxide 400 mg oral tablet, one tablet twice daily for two weeks | One tablet twice daily for two weeks | Oral route | 2026-03-02 to 2026-03-16 | completed | S |
| Naltrexone 50 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-09 to 2026-03-30 | completed | S |
| Extended-release naltrexone 380 mg by deep intramuscular injection into the buttock every four weeks, given by the clinic nurse | 380 mg intramuscularly every four weeks | Intramuscular route | 2026-03-30 | active | S |
| Amoxicillin 500 mg oral capsule, one capsule three times daily for five days | One capsule three times daily for five days | Oral route | 2026-03-23 to 2026-03-28 | completed | S |
| Ibuprofen 400 mg oral tablet, one tablet with food every 8 hours as needed for tooth pain, for up to five days | One tablet with food every 8 hours as needed, up to five days | Oral route | 2026-03-23 to 2026-03-28 | completed | S |
| Acetaminophen 500 mg oral tablet, one tablet every 6 hours as needed with the ibuprofen, no more than 2,000 mg a day, for up to five days | One tablet every 6 hours as needed, no more than 2,000 mg a day | Oral route | 2026-03-23 to 2026-03-28 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-04-27 | Body height | 165 | cm | S |
| 2026-04-27 | Body weight | 51.4 | kg | S |
| 2026-04-27 | Body mass index (BMI) [Ratio] | 18.9 | kg/m2 | S |
| 2026-04-27 | Systolic blood pressure | 120 | mm[Hg] | S |
| 2026-04-27 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-04-27 | Heart rate | 76 | /min | S |
| 2026-04-27 | Respiratory rate | 16 | /min | S |
| 2026-04-27 | Body temperature | 36.6 | Cel | S |
| 2026-04-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-04-27 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | {score} | S | ||
| 2026-04-27 | Cholesterol [Mass/volume] in Serum or Plasma | 168 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-04-27 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 72 | mg/dL | >=50 mg/dL | Normal | S |
| 2026-04-27 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 80 | mg/dL | <=99 mg/dL | Normal | S |
| 2026-04-27 | Triglyceride [Mass/volume] in Serum or Plasma | 82 | mg/dL | <=149 mg/dL | Normal | S |
Vital signs recorded on 2026-04-27; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Thin, well; weight 51.4 kg, BMI 18.9; blood pressure 120/76; pulse 76 |
| Eyes | No scleral icterus |
| Mouth | Extraction socket healed; several other decayed teeth |
| Neck | No thyroid enlargement or nodes |
| Breasts | Examined with her consent and a chaperone present; no masses |
| Cardiovascular | Regular rhythm; no murmur |
| Respiratory | Clear to auscultation |
| Abdomen | Soft and non-tender; liver edge not palpable; no ascites |
| Skin | No spider angiomas or palmar erythema |
| Neurological | No tremor; gait steady |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Alcohol use disorder, severe (nine of eleven DSM-5-TR criteria), daily drinking of about a pint of whiskey with heavier binges for many years; synthetic modern episode linked to her documented lifelong heavy drinking | active | confirmed | F10.20 | S — Synthetic modern coding; DSM-5-TR severe alcohol use disorder maps to F10.20 when withdrawal is coded separately. Person-first language; not a claim about her real diagnosis. |
| Alcohol withdrawal, mild, at low risk of complications (PAWSS 3, CIWA-Ar 9 at intake; no past seizures or delirium tremens), managed as an outpatient with daily nurse checks | resolved | confirmed | F10.230 | S — Synthetic withdrawal episode; resolved by the one-week visit. |
| Raised liver enzymes (AST 96, ALT 44, GGT 240 U/L) with a FIB-4 index of 3.93, above the cut point for possible advanced fibrosis; liver stiffness measurement planned | resolved | confirmed | R74.01 | S — Synthetic presenting finding; superseded when elastography and the clinical picture supported alcohol-associated steatotic liver disease. |
| Alcohol-associated steatotic liver disease, without cirrhosis: liver stiffness 9.6 kPa after four weeks without alcohol, falling enzymes, normal bilirubin, albumin, INR and platelets | active | confirmed | K70.0 | S — Synthetic modern diagnosis made at the four-week visit. |
| Depressive symptoms during heavy drinking (PHQ-9 14, item 9 scored 0); whether they are alcohol-induced or an independent depression to be judged after two to four weeks without alcohol | active | provisional | F32.A | S — Synthetic provisional finding; resolved as the PHQ-9 fell to 5 after ten weeks without alcohol, consistent with alcohol-induced depressive symptoms. Not a claim about her real mood. |
| Daily chewing tobacco for many years; not ready to stop at intake | active | confirmed | F17.220 | S — Synthetic modern coding anchored to the documented chewing tobacco. |
| Underweight (BMI 18.4) with poor food intake, low folate, magnesium and phosphate, and slightly low albumin | active | confirmed | R63.6 | S — Synthetic finding anchored to a contemporary impression of poor nutrition (R). |
| Housing instability: staying in a spare room at a friend's house, with nowhere to go if that ends; has stayed in shelters in past winters | active | confirmed | Z59.811 | S — Synthetic social need anchored to her documented poverty and moves from town to town. |
| Food insecurity: often goes without meals at the end of the month | active | confirmed | Z59.41 | S — Synthetic social need anchored to her documented poverty. |
| Periapical abscess of a lower left molar with facial swelling and low-grade fever, on naltrexone; treated without opioids, tooth removed at the dental clinic the next day; resolved | resolved | confirmed | K04.7 | S — Synthetic acute illness; not a historical claim. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 120/76 mmHg |
| Cervical cancer screening | Completed today | No screening she can recall; HPV test on a self-collected sample today |
| Breast cancer screening | Ordered | Mammography every two years from 40; ordered at the mobile unit, with transport arranged |
| Colorectal cancer screening | Not indicated | Begins at 45, next year |
| Lipid screening and cardiovascular risk | Completed today | Total cholesterol 168, HDL 72, LDL 80, triglycerides 82 mg/dL; 10-year risk low; statin not indicated |
| Diabetes screening | Not indicated | Recommended at 35 to 70 for adults with overweight or obesity; BMI 18.9 |
| HIV screening | Up to date | Negative at intake |
| Hepatitis C screening | Up to date | Antibody negative at intake |
| Hepatitis B screening | Up to date | Triple panel at intake: not infected and not immune |
| Latent tuberculosis screening | Ordered | Interferon-gamma release assay today; she has stayed in shelters |
| Intimate partner violence screening | Completed today | Negative now; past violence by a former partner, discussed only as far as she wished |
| Depression screening | Completed today | PHQ-9 7, from 14 at intake; item 9 scored 0 |
| Unhealthy alcohol use | Up to date | In treatment; no alcohol for eight weeks |
| Tobacco cessation | Declined | Chews tobacco daily; advice given and nicotine lozenges offered; she will be asked again at each visit |
| Tetanus, diphtheria, and pertussis | Completed today | Tdap today |
| Hepatitis B vaccine | Completed today | First of two HepB-CpG doses; second in one month or more |
| Hepatitis A vaccine | Completed today | First of two doses for chronic liver disease; second in six months |
| Pneumococcal vaccine | Completed today | PCV20 today; indicated by alcohol use disorder and chronic liver disease |
| Influenza vaccine | Not indicated | Season over; to be given in the autumn |
| HPV vaccine | Declined | Shared decision-making for adults 27 to 45; she chose not to have it |
Immunizations given today: Tdap vaccine; no tetanus booster she can recall; Hepatitis B vaccine (HepB-CpG), first of two doses; not immune at intake; Hepatitis A vaccine, adult, first of two doses; Pneumococcal conjugate vaccine (PCV20) [S]
Guideline basis: The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)
Follow-up: Ten-week review in two weeks. HPV, tuberculosis test and mammogram results at the next visits. Second hepatitis B dose in one month or more; second hepatitis A dose in six months. Naltrexone injection at a nurse visit in four weeks. Next preventive visit in one year. Next scheduled visit 2026-05-11: ten-week review: recovery, mood, housing and results. [S]
Voluntary advance care planning discussion of about 16 minutes, with her consent. She named a health care agent, the friend she is staying with, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. She said that what matters most to her is her independence and her friends, and that she wants to be told the truth about her health in plain words. She chose not to record specific treatment preferences today. The plan will be revisited yearly or after any serious illness. [S]